These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38327114)

  • 1. Combination of 5% cysteamine and 4% nicotinamide in melasma: Efficacy, tolerability, and safety.
    Crocco EI; Torloni L; Fernandes PB; de Campos MEBB; Gonzaga M; Silva FC; Nasario JPS; Guerra LO; Csipak AR; Castilho VC
    J Cosmet Dermatol; 2024 May; 23(5):1703-1712. PubMed ID: 38327114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, Safety, Satisfaction, Adherence to Treatment With Nano-Formulated Cysteamine Tranexamic Acid Cream to Treat Melasma.
    Khatri KA; Abdullah NA; Chia S; Ng E; Thibroni N
    J Drugs Dermatol; 2024 Jul; 23(7):529-537. PubMed ID: 38954613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of efficacy and tolerability of cysteamine 5% cream in comparison with tranexamic acid mesotherapy in subjects with melasma: a single-blind, randomized clinical trial study.
    Karrabi M; Mansournia MA; Sharestanaki E; Abdollahnejad Y; Sahebkar M
    Arch Dermatol Res; 2021 Sep; 313(7):539-547. PubMed ID: 32879998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of topical 5% cysteamine versus 4% hydroquinone in the treatment of facial melasma in women.
    Lima PB; Dias JAF; Cassiano D; Esposito ACC; Bagatin E; Miot LDB; Miot HA
    Int J Dermatol; 2020 Dec; 59(12):1531-1536. PubMed ID: 32864760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial.
    Mansouri P; Farshi S; Hashemi Z; Kasraee B
    Br J Dermatol; 2015 Jul; 173(1):209-17. PubMed ID: 25251767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy of cysteamine 5% cream and hydroquinone 4%/ascorbic acid 3% combination cream in the treatment of epidermal melasma.
    Sepaskhah M; Karimi F; Bagheri Z; Kasraee B
    J Cosmet Dermatol; 2022 Jul; 21(7):2871-2878. PubMed ID: 35510765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of efficacy, safety and tolerability of cysteamine 5% cream in comparison with modified Kligman's formula in subjects with epidermal melasma: A randomized, double-blind clinical trial study.
    Karrabi M; David J; Sahebkar M
    Skin Res Technol; 2021 Jan; 27(1):24-31. PubMed ID: 32585079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel cream formulation containing nicotinamide 4%, arbutin 3%, bisabolol 1%, and retinaldehyde 0.05% for treatment of epidermal melasma.
    Crocco EI; Veasey JV; Boin MF; Lellis RF; Alves RO
    Cutis; 2015 Nov; 96(5):337-42. PubMed ID: 26682557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteamine Isobionic-Amide Complex Versus Kligman's Formula for the Treatment of Melasma: Equal Efficacy and Rapid Onset of Action.
    Sachdev M; Grimes PE; Callender V; Hartman CL; Taylor SC; Elbuluk N; Badawi A; Funasaka Y; Lim J; Ng CY; Desai SR
    J Drugs Dermatol; 2024 Feb; 23(2):9-16. PubMed ID: 38306138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of glycolic acid peel and topical 20% azelaic acid cream in melasma patients: efficacy and improvement in quality of life.
    Dayal S; Sahu P; Dua R
    J Cosmet Dermatol; 2017 Mar; 16(1):35-42. PubMed ID: 27500896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a new measurement method: a randomized double blind placebo controlled study.
    Farshi S; Mansouri P; Kasraee B
    J Dermatolog Treat; 2018 Mar; 29(2):182-189. PubMed ID: 28678558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cream of herbal mixture to improve melasma.
    Zhang Q; Tu Y; Gu H; Sun D; Wu W; Man MQ; Chen H; Liu H; Ma X; He L
    J Cosmet Dermatol; 2019 Dec; 18(6):1721-1728. PubMed ID: 30980618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical isoniazid as a novel treatment for melasma: A randomized, double-blind, vehicle-controlled clinical trial.
    Ahramiyanpour N; Mahmoudi Z; Nezhad NZ; Khazaeli P; Amiri R; Kasraee B
    J Cosmet Dermatol; 2024 Aug; 23(8):2636-2643. PubMed ID: 38581222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: A randomised, double-blinded trial.
    Nguyen J; Remyn L; Chung IY; Honigman A; Gourani-Tehrani S; Wutami I; Wong C; Paul E; Rodrigues M
    Australas J Dermatol; 2021 Feb; 62(1):e41-e46. PubMed ID: 32981068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel triple combination in treatment of melasma: Significant outcome with far less actives.
    Pekmezci E
    J Cosmet Dermatol; 2019 Dec; 18(6):1700-1704. PubMed ID: 30920111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is cysteamine use effective in the treatment of melasma? A systematic review and meta-analysis.
    Dos Santos-Neto AG; da Silva ÍCV; Melo CR; Santana AAM; de Albuquerque-Junior RLC
    Dermatol Ther; 2022 Dec; 35(12):e15961. PubMed ID: 36285354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant therapeutic response to cysteamine cream in a melasma patient resistant to Kligman's formula.
    Kasraee B; Mansouri P; Farshi S
    J Cosmet Dermatol; 2019 Feb; 18(1):293-295. PubMed ID: 30537063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage.
    Rendon M; Dryer L
    J Drugs Dermatol; 2016 Apr; 15(4):466-75. PubMed ID: 27050702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of a depigmenting gel serum comprising tranexamic acid, niacinamide, 4-butylresorcinol, phytic acid, and a mixture of hydroxy acids that targets the biological processes regulating skin melanogenesis.
    Furmanczyk M; Brown A; Bustos J; de Henestrosa ARF; Trullas C; Granger C; Jourdan E
    J Cosmet Dermatol; 2024 Jun; 23(6):2058-2065. PubMed ID: 38549196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of liposome-encapsulated 4-n-butylresorcinol and resveratrol cream in the treatment of melasma.
    Kwon SH; Yang JH; Shin JW; Park KC; Huh CH; Na JI
    J Cosmet Dermatol; 2020 Apr; 19(4):891-895. PubMed ID: 31347777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.